miR-26a is required for skeletal muscle differentiation and regeneration in mice

Genes and Development

Volumn 26, Issue 19, 2012, Pages 2180-2191

  Dey, Bijan K ^a   Gagan, Jeffrey ^a   Yan, Zhen ^a   Dutta, Anindya ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Differentiation; MiR 26a; Myoblast; Regeneration; Skeletal muscle stem cells; TGF BMP

Indexed keywords

ADENOVIRUS VECTOR; ANTISENSE OLIGONUCLEOTIDE; BONE MORPHOGENETIC PROTEIN; MICRORNA 26A; SMAD1 PROTEIN; SMAD4 PROTEIN; TRANSCRIPTION FACTOR PAX7; TRANSFORMING GROWTH FACTOR BETA;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ARTICLE; HUMAN; HUMAN CELL; MOUSE; MUSCLE DEVELOPMENT; MUSCLE INJURY; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKELETAL MUSCLE; TIBIALIS ANTERIOR MUSCLE; UPREGULATION;

3' UNTRANSLATED REGIONS; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE KNOCKDOWN TECHNIQUES; MICE; MICRORNAS; MUSCLE, SKELETAL; MYOBLASTS; OLIGORIBONUCLEOTIDES, ANTISENSE; PAX7 TRANSCRIPTION FACTOR; REGENERATION; TRANSCRIPTION FACTORS; UP-REGULATION;

ADENO-ASSOCIATED VIRUS; ANIMALIA; MUS;

EID: 84867170366     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.198085.112     Document Type: Article

References (57)

1. Andres V, Walsh K. 1996. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol 132: 657-666.
2. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
3. Berkes CA, Tapscott SJ. 2005. MyoD and the transcriptional control of myogenesis. Semin Cell Dev Biol 16: 585-595.
4. Buckingham M, Bajard L, Daubas P, Esner M, Lagha M, Relaix F, Rocancourt D. 2006. Myogenic progenitor cells in the mouse embryo are marked by the expression of Pax3/7 genes that regulate their survival and myogenic potential. Anat Embryol 211: 51-56.
5. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ. 2006. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38: 228-233.
6. Chen JF, Callis TE, Wang DZ. 2009. MicroRNAs and muscle disorders. J Cell Sci 122: 13-20.
7. Ciarapica R, Russo G, Verginelli F, Raimondi L, Donfrancesco A, Rota R, Giordano A. 2009. Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma. Cell Cycle 8: 172-175.
8. Dey BK, Gagan J, Dutta A. 2011. miR-206 and -486 induce myoblast differentiation by downregulating Pax7. Mol Cell Biol 31: 203-214.
9. Dhawan J, Rando TA. 2005. Stem cells in postnatal myogenesis: Molecular mechanisms of satellite cell quiescence, activation and replenishment. Trends Cell Biol 15: 666-673.
10. Dupont S, Zacchigna L, Cordenonsi M, Soligo S, Adorno M, Rugge M, Piccolo S. 2005. Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell 121: 87-99.
11. Eisenberg I, Eran A, Nishino I, Moggio M, Lamperti C, Amato AA, Lidov HG, Kang PB, North KN, Mitrani-Rosenbaum S, et al. 2007. Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci 104: 17016-17021.
12. Gagan J, Dey BK, Layer R, Yan Z, Dutta A. 2011. MicroRNA-378 targets the myogenic repressor MyoR during myoblast differentiation. J Biol Chem 286: 19431-19438.
13. Gagan J, Dey BK, Dutta A. 2012. MicroRNAs regulate and provide robustness to the myogenic transcriptional network. Curr Opin Pharmacol 12: 383-388.
14. Ge Y, Chen J. 2011. MicroRNAs in skeletal myogenesis. Cell Cycle 10: 441-448.
15. Haraguchi T, Ozaki Y, Iba H. 2009. Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucleic Acids Res 37: e43. doi: 10.1093/nar/gkp040.
16. Hata A, Lagna G, Massague J, Hemmati-Brivanlou A. 1998. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev 12: 186-197.
17. Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, Richardson MA, Topper JN, Gimbrone MA Jr, Wrana JL, et al. 1997. The MAD-related protein Smad7 associates with the TGFb receptor and functions as an antagonist of TGFβ signaling. Cell 89: 1165-1173.
18. Hollnagel A, Oehlmann V, Heymer J, Ruther U, Nordheim A. 1999. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J Biol Chem 274: 19838-19845.
19. Inagaki K, Fuess S, Storm TA, Gibson GA, McTiernan CF, Kay MA, Nakai H. 2006. Robust systemic transduction with AAV9 vectors in mice: Efficient global cardiac gene transfer superior to that of AAV8. Mol Ther 14: 45-53.
20. Jalava P, Kuopio T, Juntti-Patinen L, Kotkansalo T, Kronqvist P, Collan Y. 2006. Ki67 immunohistochemistry: A valuable marker in prognostication but with a risk of misclassification: Proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index. Histopathology 48: 674-682.
21. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T. 1994. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127: 1755-1766.
22. Katagiri T, Imada M, Yanai T, Suda T, Takahashi N, Kamijo R. 2002. Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis. Genes Cells 7: 949-960.
23. Kim HK, Lee YS, Sivaprasad U, Malhotra A, Dutta A. 2006. Muscle-specific microRNA miR-206 promotes muscle differentiation. J Cell Biol 174: 677-687.
24. Kowanetz M, Valcourt U, Bergstrom R, Heldin CH, Moustakas A. 2004. Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor b and bone morphogenetic protein. Mol Cell Biol 24: 4241-4254.
25. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. 2005. Silencing of microRNAs in vivo with 'antagomirs.' Nature 438: 685-689.
26. Kuisk IR, Li H, Tran D, Capetanaki Y. 1996. A single MEF2 site governs desmin transcription in both heart and skeletal muscle during mouse embryogenesis. Dev Biol 174: 1-13.
27. Leeper NJ, Raiesdana A, Kojima Y, Chun HJ, Azuma J, Maegdefessel L, Kundu RK, Quertermous T, Tsao PS, Spin JM. 2011. MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol 226: 1035-1043.
28. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM. 2005. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773.
29. Liu D, Black BL, Derynck R. 2001. TGF-b inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev 15: 2950-2966.
30. Liu D, Kang JS, Derynck R. 2004. TGF-b-activated Smad3 represses MEF2-dependent transcription in myogenic differentiation. EMBO J 23: 1557-1566.
31. Liu N, Williams AH, Maxeiner JM, Bezprozvannaya S, Shelton JM, Richardson JA, Bassel-Duby R, Olson EN. 2012. MicroRNA- 206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. J Clin Invest 122: 2054-2065.
32. Martin JF, Li L, Olson EN. 1992. Repression of myogenin function by TGF-β1 is targeted at the basic helix-loop-helix motif and is independent of E2A products. J Biol Chem 267: 10956-10960.
33. Massague J. 1998. TGF-b signal transduction. Annu Rev Biochem 67: 753-791.
34. Massague J, Cheifetz S, Endo T, Nadal-Ginard B. 1986. Type b transforming growth factor is an inhibitor of myogenic differentiation. Proc Natl Acad Sci 83: 8206-8210.
35. McCarthy JJ, Mula J, Miyazaki M, Erfani R, Garrison K, Farooqui AB, Srikuea R, Lawson BA, Grimes B, Keller C, et al. 2011. Effective fiber hypertrophy in satellite celldepleted skeletal muscle. Development 138: 3657-3666.
36. McPherron AC, Lee SJ. 1997. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci 94: 12457-12461.
37. Michelfelder S, Trepel M. 2009. Adeno-associated viral vectors and their redirection to cell-type specific receptors. Adv Genet 67: 29-60.
38. Ono Y, Calhabeu F, Morgan JE, Katagiri T, Amthor H, Zammit PS. 2011. BMP signalling permits population expansion by preventing premature myogenic differentiation in muscle satellite cells. Cell Death Differ 18: 222-234.
39. O'Rourke JR, Georges SA, Seay HR, Tapscott SJ, McManus MT, Goldhamer DJ, Swanson MS, Harfe BD. 2007. Essential role for Dicer during skeletal muscle development. Dev Biol 311: 359-368.
40. Potthoff MJ, Olson EN. 2007. MEF2: A central regulator of diverse developmental programs. Development 134: 4131-4140.
41. Re'Em-Kalma Y, Lamb T, Frank D. 1995. Competition between noggin and bone morphogenetic protein 4 activities may regulate dorsalization during Xenopus development. Proc Natl Acad Sci 92: 12141-12145.
42. Rudnicki MA, Le Grand F, McKinnell I, Kuang S. 2008. The molecular regulation of muscle stem cell function. Cold Spring Harb Symp Quant Biol 73: 323-331.
43. Sarkar S, Dey BK, Dutta A. 2010. miR-322/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A. Mol Biol Cell 21: 2138-2149.
44. Schmierer B, Hill CS. 2007. TGFb-SMAD signal transduction: Molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 8: 970-982.
45. Silahtaroglu AN, Nolting D, Dyrskjot L, Berezikov E, Moller M, Tommerup N, Kauppinen S. 2007. Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using locked nucleic acid probes and tyramide signal amplification. Nat Protoc 2: 2520-2528.
46. Springer ML, Rando TA, Blau HM. 2002. Gene delivery to muscle. Curr Protoc Hum Genet 13.4.1-13.4.19. doi: 10.1002/0471142905.hg1304s31.
47. Wang H, Noulet F, Edom-Vovard F, Tozer S, Le Grand F, Duprez D. 2010. Bmp signaling at the tips of skeletal muscles regulates the number of fetal muscle progenitors and satellite cells during development. Dev Cell 18: 643-654.
48. Wang S, Guo L, Dong L, Li S, Zhang J, Sun M. 2010. TGF-b1 signal pathway may contribute to rhabdomyosarcoma development by inhibiting differentiation. Cancer Sci 101: 1108-1116.
49. Williams AH, Liu N, van Rooij E, Olson EN. 2009a. MicroRNA control of muscle development and disease. Curr Opin Cell Biol 21: 461-469.
50. Williams AH, Valdez G, Moresi V, Qi X, McAnally J, Elliott JL, Bassel-Duby R, Sanes JR, Olson EN. 2009b. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326: 1549-1554.
51. Wong CF, Tellam RL. 2008. MicroRNA-26a targets the histone methyltransferase Enhancer of Zeste homolog 2 during myogenesis. J Biol Chem 283: 9836-9843.
52. Wu L, Fan J, Belasco JG. 2006. MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci 103: 4034-4039.
53. Yaffe D, Saxel O. 1977. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270: 725-727.
54. Yamashita M, Ying SX, Zhang GM, Li C, Cheng SY, Deng CX, Zhang YE. 2005. Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation. Cell 121: 101-113.
55. Yan Z, Choi S, Liu X, Zhang M, Schageman JJ, Lee SY, Hart R, Lin L, Thurmond FA, Williams RS. 2003. Highly coordinated gene regulation in mouse skeletal muscle regeneration. J Biol Chem 278: 8826-8836.
56. Zhao Y, Samal E, Srivastava D. 2005. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436: 214-420.
57. Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN, Tsuchihashi T, McManus MT, Schwartz RJ, Srivastava D. 2007. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129: 303-317.